The Eris Lifesciences IPO will be yet another major exit for ChrysCapital, which has sold shares in Mankind Pharma and Intas Pharmaceuticals
The Eris Lifesciences IPO will be yet another major exit for ChrysCapital, which has sold shares in Mankind Pharma and Intas Pharmaceuticals